Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Goldschmidt

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
Journal of Immunology (Baltimore, Md. : 1950)|May 9, 2001
Cutting edge: systemic inhibition of angiogenesis underlies resistance to tumors during acute toxoplasmosisC A Hunter, D Yu, M Gee, et al.
Bioorganic & Medicinal Chemistry Letters|June 30, 2006
Antibacterial activity of pyrrolopyridine-substituted oxazolidinones: synthesis and in vitro SAR of various C-5 acetamide replacementsSteven D Paget, Christine M Boggs, Barbara D Foleno, et al.
Acta Dermato-Venereologica|January 17, 2007
Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in childrenAnita Remitz, John Harper, Malcolm Rustin, et al.
Journal of Veterinary Internal Medicine|December 22, 2015
Effect of Ovariohysterectomy at the Time of Tumor Removal in Dogs with Mammary Carcinomas: A Randomized Controlled TrialV M Kristiansen, L Peña, L Díez Córdova, et al.
Bioorganic & Medicinal Chemistry Letters|November 19, 2003
Synthesis and antibacterial activity of pyrroloaryl-substituted oxazolidinonesSteven D Paget, Barbara D Foleno, Christine M Boggs, et al.
The New England Journal of Medicine|August 15, 2003
Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasisVera M R Heydendael, Phyllis I Spuls, Brent C Opmeer, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2007
Tetrahydroindazole inhibitors of bacterial type II topoisomerases. Part 2: SAR development and potency against multidrug-resistant strainsJohn J M Wiener, Laurent Gomez, Hariharan Venkatesan, et al.
Journal of Medicinal Chemistry|July 31, 1998
Substituted salicylanilides as inhibitors of two-component regulatory systems in bacteriaM J Macielag, J P Demers, S A Fraga-Spano, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 1998
Antibacterial agents that inhibit two-component signal transduction systemsJ F Barrett, R M Goldschmidt, L E Lawrence, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 18, 2012
Bortezomib induction and maintenance treatment in patients with newly diagnosed multiple myeloma: results of the randomized phase III HOVON-65/ GMMG-HD4 trialPieter Sonneveld, Ingo G H Schmidt-Wolf, Bronno van der Holt, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Journal of Immunology (Baltimore, Md. : 1950)|May 9, 2001
Cutting edge: systemic inhibition of angiogenesis underlies resistance to tumors during acute toxoplasmosisC A Hunter, D Yu, M Gee, et al.
Bioorganic & Medicinal Chemistry Letters|June 30, 2006
Antibacterial activity of pyrrolopyridine-substituted oxazolidinones: synthesis and in vitro SAR of various C-5 acetamide replacementsSteven D Paget, Christine M Boggs, Barbara D Foleno, et al.
Acta Dermato-Venereologica|January 17, 2007
Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in childrenAnita Remitz, John Harper, Malcolm Rustin, et al.
Journal of Veterinary Internal Medicine|December 22, 2015
Effect of Ovariohysterectomy at the Time of Tumor Removal in Dogs with Mammary Carcinomas: A Randomized Controlled TrialV M Kristiansen, L Peña, L Díez Córdova, et al.
Bioorganic & Medicinal Chemistry Letters|November 19, 2003
Synthesis and antibacterial activity of pyrroloaryl-substituted oxazolidinonesSteven D Paget, Barbara D Foleno, Christine M Boggs, et al.
The New England Journal of Medicine|August 15, 2003
Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasisVera M R Heydendael, Phyllis I Spuls, Brent C Opmeer, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2007
Tetrahydroindazole inhibitors of bacterial type II topoisomerases. Part 2: SAR development and potency against multidrug-resistant strainsJohn J M Wiener, Laurent Gomez, Hariharan Venkatesan, et al.
Journal of Medicinal Chemistry|July 31, 1998
Substituted salicylanilides as inhibitors of two-component regulatory systems in bacteriaM J Macielag, J P Demers, S A Fraga-Spano, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 1998
Antibacterial agents that inhibit two-component signal transduction systemsJ F Barrett, R M Goldschmidt, L E Lawrence, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 18, 2012
Bortezomib induction and maintenance treatment in patients with newly diagnosed multiple myeloma: results of the randomized phase III HOVON-65/ GMMG-HD4 trialPieter Sonneveld, Ingo G H Schmidt-Wolf, Bronno van der Holt, et al.
Pageof 11